Table 3.
Study identifiers, context, and population | Study design and limitations | |||||||
---|---|---|---|---|---|---|---|---|
Study (first-named author, year of publication) | Country | Study years | Study population | Study design | Sample size and number of total clusters | Ascertainment of deaths | Co-interventions | Intervention coverage |
Studies with all-cause data | ||||||||
Kidane, 2000 [22] | Ethiopia | 1997 | 0–59 mo. | Cluster-matched RCT | 13 677 children, 24 clusters | VA reported by study coordinators | None | NR |
Menon, 1990 [23] | The Gambia | 1985–89 | 3–59 mo. | Cluster, but not randomized | 41 villages | VA reported by a physician | No | 60% received maloprim chemoprophylaxis, chloroquine coverage not reported |
NR, Not reported; RCT, randomized controlled trial; VA, verbal autopsy.